Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugsMathias Gehrmann, Marion Brunner, Karin Pfister, et al.
Frontiers in Pharmacology|November 29, 2018
Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AMLDaniel Heudobler, Sebastian Klobuch, Simone Thomas, et al.
Frontiers in Oncology|November 2, 2020
Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case ReportDennis Christoph Harrer, Karin Menhart, Stephanie Mayer, et al.
Frontiers in Oncology|May 12, 2020
Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory TherapyAnna-Sophia Kattner, Ernst Holler, Wolfgang Herr, et al.
Frontiers in Pharmacology|April 4, 2025
MEPED as salvage therapy for relapsed/refractory Hodgkin's lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneckDennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Cancers|January 11, 2024
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell ResistanceDennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Frontiers in Pharmacology|March 12, 2026
Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasiasDennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Frontiers in Oncology|January 26, 2024
Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticityDennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Archives of Dermatology|December 22, 2004
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcomaBrigitte Coras, Christian Hafner, Albrecht Reichle, et al.
Annals of Hematology|April 6, 2011
Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stromaMárk Plander, Peter Ugocsai, Silvia Seegers, et al.
Pageof 8